Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar-Apr;60(2):111-7.
doi: 10.4103/0019-5154.152501.

Male genital lichen sclerosus

Christopher Barry Bunker  1 , Tang Ngee Shim  1
Affiliations
Review

Male genital lichen sclerosus

Christopher Barry Bunker et al. Indian J Dermatol. 2015 Mar-Apr.

Abstract

Male genital lichen sclerosus (MGLSc) is a chronic inflammatory skin disease responsible for male sexual dyspareunia and urological morbidity. An afeared complication is squamous cell carcinoma (SCC) of the penis. The precise etiopathogenesis of MGLSc remains controversial although genetic, autoimmune and infective (such as human papillomavirus (HPV) hepatitis C (HCV), Epstein-Barr virus (EBV) and Borrelia) factors have been implicated: Consideration of all the evidence suggests that chronic exposure of susceptible epithelium to urinary occlusion by the foreskin seems the most likely pathomechanism. The mainstay of treatment is topical ultrapotent corticosteroid therapy. Surgery is indicated for cases unresponsive to topical corticosteroid therapy, phimosis, meatal stenosis, urethral stricture, carcinoma in situ (CIS) and squamous cell carcinoma.

Keywords: Male genital lichen sclerosus; etiology; management; pathogenesis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

References

    1. Bunker CB. London: Saunders; 2004. Male genital skin disease.
    1. Bunker CB, Porter WM. Rook's Textbook of Dermatology. 9th ed. New York: Wiley-Blackwell; 2015. Male genital dermatology. In Press.
    1. Wallace HJ. Lichen sclerosus et atrophicus. Trans St John's Dermatol Soc (England) 1971;57:9–30. - PubMed
    1. Nelson DM, Peterson AC. Lichen sclerosus: Epidemiological distribution in an equal access health care system. J Urol. 2011;185:522–5. - PubMed
    1. Lipscombe TK, Wayte J, Wojnarowska F, Marren P, Luzzi G. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol. 1997;38:132–6. - PubMed